Search Results - "Couselo EM"

Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune response on drug exposure.

Authors: Spreafico A Couselo EM Irmisch A et al.

Source: Frontiers in oncology [Front Oncol] 2024 Mar 21; Vol. 14, pp. 1346502. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study.

Authors: Mandalà M Amaral T Rutkowski P et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Jul 25; Vol. 225, pp. 115567. Date of Electronic Publication: 2025 Jun 09.

Publication Type: Comparative Study; Journal Article; Multicenter Study

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma - Results of systematic literature research.

Authors: Amaral T Nanz L Higuita LMS et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Jan 17; Vol. 215, pp. 115160. Date of Electronic Publication: 2024 Dec 13.

Publication Type: Journal Article; Systematic Review; Comparative Study

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study.

Authors: Mandalà M Lorigan P Sergi MC et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Mar; Vol. 199, pp. 113542. Date of Electronic Publication: 2024 Jan 19.

Publication Type: Multicenter Study; Journal Article

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Unraveling the molecular evolution and immune functions of Lr-CD40 in Lethenteron reissneri.

Authors: Zhao L Yan Z Du M et al.

Source: Fish physiology and biochemistry [Fish Physiol Biochem] 2026 Jul 30; Vol. 52 (4). Date of Electronic Publication: 2026 Jul 30.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 100955049 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-5168 (Electronic) Linking ISSN: 09201742 NLM ISO Abbreviation: Fish Physiol Biochem Subsets: MEDLINE

Dendritic cell diversity and dysfunction in cancer: implications for immunotherapy and therapeutic targeting.

Authors: Wang R Chen Y Fang YF

Source: Acta pharmacologica Sinica [Acta Pharmacol Sin] 2026 Jul 09. Date of Electronic Publication: 2026 Jul 09.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-7254 (Electronic) Linking ISSN: 16714083 NLM ISO Abbreviation: Acta Pharmacol Sin Subsets: MEDLINE

Cell Death of Tumor Melanocytes and Treatment Options.

Authors: Koval, Olga Zhilnikova, Maria Balantaeva, Maria et al.

Source: Biocell. 2025, Vol. 49 Issue 3, p355-379. 25p.

Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients.

Authors: Grauers Wiktorin H Ekström-Rydén V Ek I et al.

Source: Biomarker research [Biomark Res] 2026 Mar 27; Vol. 14 (1). Date of Electronic Publication: 2026 Mar 27.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101607860 Publication Model: Electronic Cited Medium: Print ISSN: 2050-7771 (Print) Linking ISSN: 20507771 NLM ISO Abbreviation: Biomark Res Subsets: PubMed not MEDLINE

The double-edged sword role of tumor-associated macrophages: preventing or causing resistance to immunotherapy.

Authors: Roudi R Beikzadeh B Kalantari S et al.

Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2026 Mar 18; Vol. 45 (1). Date of Electronic Publication: 2026 Mar 18.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

Immunotherapy for Renal Cell Carcinoma-What More is to Come?

Authors: Yochum ZA Braun DA

Source: Targeted oncology [Target Oncol] 2025 May; Vol. 20 (3), pp. 467-483. Date of Electronic Publication: 2025 Apr 10.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

Immune dynamics shaping pre-metastatic and metastatic niches in liver metastases: from molecular mechanisms to therapeutic strategies.

Authors: Zhu, Chang Liao, Jing-Yu Liu, Yi-Yang et al.

Source: Molecular Cancer. 11/14/2024, Vol. 23 Issue 1, p1-25. 25p.

In Vivo Clearance of Immune Complexes: Insights Into Human Drug/Anti-Drug Antibody Complex Clearance Dynamics.

Authors: Opolka-Hoffmann E Fowler S Bach T et al.

Source: The AAPS journal [AAPS J] 2026 Feb 20; Vol. 28 (2). Date of Electronic Publication: 2026 Feb 20.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: a multicountry retrospective chart review.

Authors: Mohr P Kiecker F Soriano V et al.

Source: Melanoma management [Melanoma Manag] 2019 Oct 04; Vol. 6 (4), pp. MMT33. Date of Electronic Publication: 2019 Oct 04.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101649842 Publication Model: Electronic Cited Medium: Print ISSN: 2045-0885 (Print) Linking ISSN: 20450885 NLM ISO Abbreviation: Melanoma Manag Subsets: PubMed not MEDLINE

Leveraging in vitro Tumor Cell Killing and Cytokine Release to Predict Cytokine Release Syndrome Associated with CD3 T-cell Bispecifics in Oncology: a Retrospective Analysis.

Authors: Lefèvre A Parra-Guillen ZP Trocóniz IF et al.

Source: The AAPS journal [AAPS J] 2025 Nov 18; Vol. 28 (1), pp. 20. Date of Electronic Publication: 2025 Nov 18.

Publication Type: Journal Article

Journal Info: Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

A bibliometric analysis of resistance to PD-1/PD-L1 inhibitors.

Authors: Miao L Jiang Z

Source: Frontiers in immunology [Front Immunol] 2026 May 28; Vol. 17, pp. 1788252. Date of Electronic Publication: 2026 May 28 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

The broad spectrum of cancer and immunotherapy: achievements and limitations.

Authors: Aman A Toledo B González-Titos A et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jan 12; Vol. 16, pp. 1697505. Date of Electronic Publication: 2026 Jan 12 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Case Report: The role of BRAF mutation in adjuvant and neoadjuvant treatment of melanoma patients: what is the optimal approach?

Authors: Di Pietro FR Falcone R Verkhovskaia S et al.

Source: Frontiers in oncology [Front Oncol] 2026 Apr 13; Vol. 16, pp. 1775350. Date of Electronic Publication: 2026 Apr 13 (Print Publication: 2026).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Current landscape of T-cell engagers in early-phase clinical development in solid cancers.

Authors: Spinazzola A Iannantuono GM Gulley JL et al.

Source: Frontiers in immunology [Front Immunol] 2025 Oct 06; Vol. 16, pp. 1665838. Date of Electronic Publication: 2025 Oct 06 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab.

Authors: Gogas H Ravimohan S Datta A et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2024 Jul 19; Vol. 8 (1), pp. 150. Date of Electronic Publication: 2024 Jul 19.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

First-in-human evaluation of a no-alpha interleukin-2 mutein: safety and preliminary pharmacodynamic and clinical effect.

Authors: Caballero Aguirrechu I Mestre Fernández B Soriano García JL et al.

Source: Frontiers in immunology [Front Immunol] 2025 May 23; Vol. 16, pp. 1589042. Date of Electronic Publication: 2025 May 23 (Print Publication: 2025).

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE